Bristol Myers will pay $5.8 billion for cancer drug developer Mirati Therapeutics
American pharmaceutical company Bristol Myers Squibb buys cancer drug developer Mirati Therapeutics. The corresponding agreement was signed by the companies...
American pharmaceutical company Bristol Myers Squibb buys cancer drug developer Mirati Therapeutics. The corresponding agreement was signed by the companies...
The American pharmaceutical company Bristol Myers Squibb (BMS) has entered into an agreement to purchase Mirati Therapeutics, which is developing...